Karyopharm Therapeutics Total Return Price Insights | YCharts

Karyopharm Therapeutics, Inc. (KPTI)

9.11 +0.42 (+4.83%) USD | NASDAQ | Jun 10, 16:00

9.11 0.00 (0.00%) Pre-Market: 08:09

Total Return Price Chart

View Total Return Price for KPTI.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Total Return Price Chart

Start Trial

Historical Total Return Price Data

View and export this data back to 2013. Start Trial.

Date	Value
June 10, 2026	9.11
June 09, 2026	8.69
June 08, 2026	8.50
June 05, 2026	9.08
June 04, 2026	9.07
June 03, 2026	9.00
June 02, 2026	9.23
June 01, 2026	9.82
May 29, 2026	9.10
May 28, 2026	9.11
May 27, 2026	8.98
May 26, 2026	8.97
May 22, 2026	8.16
May 21, 2026	8.06
May 20, 2026	7.98
May 19, 2026	7.47
May 18, 2026	7.14
May 15, 2026	7.67
May 14, 2026	8.90
May 13, 2026	8.85
May 12, 2026	8.915
May 11, 2026	8.81
May 08, 2026	8.64
May 07, 2026	8.85
May 06, 2026	9.02

Date	Value
May 05, 2026	9.41
May 04, 2026	9.30
May 01, 2026	8.77
April 30, 2026	8.31
April 29, 2026	8.40
April 28, 2026	8.60
April 27, 2026	8.66
April 24, 2026	8.66
April 23, 2026	8.75
April 22, 2026	9.55
April 21, 2026	9.17
April 20, 2026	8.94
April 17, 2026	8.61
April 16, 2026	8.66
April 15, 2026	8.56
April 14, 2026	8.45
April 13, 2026	8.28
April 10, 2026	8.00
April 09, 2026	8.16
April 08, 2026	7.25
April 07, 2026	7.21
April 06, 2026	6.32
April 02, 2026	5.89
April 01, 2026	5.82
March 31, 2026	5.57

Total Return Price Definition

The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.

Read full definition.

Total Return Price Range, Past 5 Years

View Total Return Price Range, Past 5 Years

Start Trial

--

Minimum

--

Maximum

--

Average

--

Median

Total Return Price Benchmarks

View Total Return Price Benchmarks

Start Trial

Gilead Sciences, Inc.	121.48
Catalyst Pharmaceuticals, Inc.	31.34
Incyte Corp.	105.39
Inovio Pharmaceuticals, Inc.	1.09
Cellectar Biosciences, Inc.	2.26